Using a CGM in pregnancy and postpartum for gestational diabetes
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether using a continuous glucose monitor (CGM) during pregnancy and after delivery helps women with gestational diabetes. It aims to see if the Dexcom G7 can improve health outcomes for both you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gestational diabetes during this pregnancy
- You are 18 years old or older
- Your doctor has prescribed the Dexcom G7 continuous glucose monitor
- You did not have diabetes before this pregnancy
- You do not have a known allergy to skin adhesives
- You are not taking oral steroids regularly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a continuous glucose monitor (CGM) for a short time after pregnancy can help women who had gestational diabetes. The monitor (Dexcom Stelo) is a small sensor that checks your blood sugar trends without fingersticks, and you wear it for up to 14 days to learn about your glucose patterns.
This study tests a continuous glucose monitor (a small patch that tracks your blood sugar) for a few weeks after you give birth. It aims to see if this tool can help women who recently had gestational diabetes better understand their blood sugar levels after delivery.
This study uses a continuous glucose monitor to check blood sugar levels after giving birth in people who had gestational diabetes. It aims to find early signs of abnormal blood sugar and may help you understand your risk for type 2 diabetes.
This study tests whether using a continuous glucose monitor (a small sensor that tracks your blood sugar) along with support from others can help prevent or manage high blood sugar during pregnancy. It is for pregnant women under 20 weeks who have certain risk factors for gestational diabetes.
This study compares a continuous glucose monitor (CGM) to standard finger-prick testing for managing gestational diabetes. It aims to see if the CGM can improve blood sugar control and maternal outcomes.
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
Hear when a new Gestational Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.